Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-18-047834
Filing Date
2018-02-16
Accepted
2018-02-16 08:02:47
Documents
51
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d449269d10k.htm 10-K 784884
2 EX-23.1 d449269dex231.htm EX-23.1 1267
3 EX-31.1 d449269dex311.htm EX-31.1 9384
4 EX-31.2 d449269dex312.htm EX-31.2 9090
5 EX-32.1 d449269dex321.htm EX-32.1 3534
6 EX-32.2 d449269dex322.htm EX-32.2 3541
  Complete submission text file 0001193125-18-047834.txt   2943121

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT hppi-20171231.xml EX-101.INS 328141
8 XBRL TAXONOMY EXTENSION SCHEMA hppi-20171231.xsd EX-101.SCH 39186
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20171231_cal.xml EX-101.CAL 36128
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20171231_def.xml EX-101.DEF 152644
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20171231_lab.xml EX-101.LAB 308306
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20171231_pre.xml EX-101.PRE 215688
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13467 | Film No.: 18619685
SIC: 8731 Services-Commercial Physical & Biological Research